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Abstract
Summary There is variation in how services to prevent sec-
ondary fractures after hip fracture are delivered and no con-
sensus on best models of care. This study identifies healthcare
professionals’ views on effective care for the prevention of
these fractures. It is hoped this will provide information on
how to develop services.
Introduction Hip fracture patients are at high risk of subse-
quent osteoporotic fractures. Whilst fracture prevention ser-
vices are recommended, there is variation in delivery and no
consensus on best models of care. This study aims to identify
healthcare professionals’ views on effective care for preven-
tion of secondary fracture after hip fracture.
Methods Forty-three semi-structured interviews were under-
taken with healthcare professionals involved in delivering
fracture prevention across 11 hospitals in one English region.
Interviews explored views on four components of care: (1)
case finding, (2) osteoporosis assessment, (3) treatment initi-
ation, and (4) monitoring and coordination. Interviews were
audio-recorded, transcribed, anonymised and coded using
NVivo software.
Results Case finding: a number of approaches were discussed.
Multiple methods ensured there was a ‘backstop’ if patients
were overlooked. Osteoporosis assessment: there was no con-
sensus on who should conduct this. The location of the dual
energy X-ray absorptiometry (DXA) scanner influenced the
likelihood of patients receiving a scan. Treatment initiation: it
was felt this was best done in inpatients rather request initia-
tion in the post-discharge/outpatients period. Monitoring (ad-
herence): adherence was a major concern, and participants felt
more monitoring could be conducted by secondary care. Co-
ordination of care: participants advocated using dedicated co-
ordinators and formal and informal methods of communica-
tion. A gap between primary and secondary care was identi-
fied and strategies suggested for addressing this.
Conclusions A number of ways of organising effective frac-
ture prevention services after hip fracture were identified. It is
hoped that this will help professionals identify gaps in care
and provide information on how to develop services.
Keywords Epidemiology . Fracture . Fragility . Hip .
Osteoporosis . Qualitative
Introduction
About 87,000 hip fractures occur annually in the UK and are
estimated to cost around £2.3 billion annually including health
and social care [1]. These fractures usually occur in individ-
uals with underlying osteoporosis [2, 3], and these are at high
risk of subsequent fractures [4] and premature death [5].
Bone protection therapies reduce the risk of subsequent
fractures [1, 6–8], and guidance has been published on how
best to organise services to prevent further fractures [1, 8–10].
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According to the International Osteoporosis Foundation, ser-
vices should be structured around four aspects of care: case
finding; osteoporosis assessment, including a dual energy X-
ray absorptiometry (DXA) scan to measure bone density if
needed; treatment initiation with bone protection therapies
for those with osteoporosis; and falls risk assessment and sys-
tems to monitor adherence to therapies [11].
To coordinate these aspects of care, services with named
clinicians responsible for coordinating the multi-disciplinary
teams, known as coordinator-based systems, are recommend-
ed [12]. However, there is no consensus on the best model of
care, and there is significant variation in the processes used by
each hospital to undertake the four main components of a
fracture prevention service and the types of coordinator-
based models in place [13].
This article identifies the elements of care of hip fracture
patients that health professionals think are most effective in
preventing secondary fractures after hip fracture. This in-
cludes the processes for undertaking the four main compo-
nents of a fracture prevention service and coordination of care.
It is hoped that this study will help inform clinicians and
service managers about which fracture prevention services to
develop in the future.
Methods
Qualitative methods were chosen as the most appropriate
means to elicit the views and experiences of professionals
working in fracture prevention services [14]. To collect infor-
mation from busy professionals, to structure data collection
around existing knowledge and to expedite analysis, the study
design comprised one-to-one interviews [15] focusing on
main components of fracture prevention and ways of coordi-
nating care [11]. In the analysis described here, we use a the-
matic approach [16]. The findings here provide information
about the delivery of fracture prevention services in practice,
complementing our theoretically driven abductive analysis
exploring the implementation of fracture prevention services
presented elsewhere [17]. Elements of study design and con-
duct are described in turn.
Sample
Professionals involved in providing services to prevent sec-
ondary fractures after hip fracture in the 11 hospitals that re-
ceive acutely hip fractured patients in one region in England
were approached to take part in this qualitative interview
study. Potential participants were identified by a clinical lead
champion in osteoporosis and an operational service manager
in traumawhowere both working within the Region. Potential
participants were then purposively sampled to ensure that par-
ticipants were drawn evenly from the 11 acute trusts and
i n c l uded a r ange o f p r o f e s s i on a l s , who we r e
orthogeriatricians, fracture prevention nurses, trauma nurses,
hospital practitioners in osteoporosis, surgeons and service
managers. In three waves of recruitment, we approached po-
tential participants by email, followed up by an additional
email 2 weeks later and a subsequent telephone call. During
the process of recruitment, we also used snowball sampling
[18] and approached other professionals who were suggested
by participants. In total, 82 professionals were contacted to
take part in the study and 43 agreed to do so. The remaining
39 were either unavailable or did not wish to take part.
Ethics
Ethical approval was provided by the Central University Re-
search Ethics Committee (CUREC) in 2012, reference num-
ber MSD-IDREC-C1-2012-147. Each involved NHS trust
provided R&D approval.
Interview procedure
Participants provided their written, informed consent before
interview. Consent included their agreement to audio-
recording of interviews and publication of anonymous quota-
tions. Interviews took place in 2013 at a time and location
convenient to the participant and lasted 30–50 min each. Most
interviews were conducted face-to-face, and one interview
took place by telephone. Using a topic guide to ensure that
she covered key topics with all participants, the researcher
asked open-ended questions about participants’ views and ex-
perience of best models of care for the prevention of second-
ary fractures after hip fracture. Interviews included focus on
the four main components of a fracture prevention service and
the best ways of coordinating care [11].
Data analysis
Interviews were audio-recorded, transcribed, anonymised and
imported into the qualitative data analysis software NVivo. A
thematic analysis was conducted by the project researcher,
which involved coding the interviews to identify themes and
subthemes in the responses [16]. Twenty percent of the inter-
views were independently coded by another member of the
team (RG-H). The coding frame was then discussed and re-
fined by the two researchers. The themes and subthemes
which were identified were then transferred onto charts using
a framework approach to data organisation [19]. This allowed
the project researcher to compare and contrast the responses of
different participants. Descriptive accounts were then gener-
ated by exploring the themes and subthemes that had emerged.
Osteoporos Int
Results
Characteristics of participants
The 43 participants comprised eight fracture prevention
nurses, four orthogeriatricians, four geriatricians, two general
practitioner (GP) osteoporosis specialists, five consultant trau-
ma orthopaedic surgeons, eight rheumatology consultants,
two orthopaedic nurses, one trauma matron, one matron for
the hip fracture unit, one falls coordinator, one falls nurse, one
bone densitometry specialist and five service managers. Be-
tween three and seven participants were drawn from each of
the 11 hospitals. Years of experience in their current role
ranged between 8 months and 32 years and time spent work-
ing at the hospital between 1 and 27 years. We found that the
views of different groups of healthcare professionals did not
differ to any great degree, and as a result, we do not distin-
guish between them in our findings.
The experiences and views of healthcare professionals and
service managers on the most effective ways of preventing
secondary fractures after hip fracture are summarised below.
This includes the processes for undertaking the four main
components of a fracture prevention service [11] and coordi-
nation of care (Fig. 1).
Case finding (Box 1)
Participants were asked to discuss their experiences of identi-
fying hip fracture patients at risk of secondary fractures: ‘case
finding’. Participants felt that such patients were relatively
easy to identify since they were invariably admitted and
remained in hospital for a period of time and therefore pre-
sented a ‘captive audience’. This was made easier when pa-
tients were located on one ward such as dedicated hip fracture
or trauma units as ‘outliers’ could be missed.
Participants felt it was important to have a named clinician
responsible for case finding rather than trauma surgeons and
to establish a systematic process of case finding with them.
The relative advantages and disadvantages of different
methods were discussed. Computerised databases provided
clinicians with information about patients which helped them
to undertake osteoporosis assessments. However, ‘human er-
ror’meant that data was maybe inputted incorrectly or patients
missed which limited its utility.
Attendance of fracture prevention coordinators or other
healthcare professionals at daily pre-operative trauma meet-
ings was seen as effective at identifying patients at risk of
further fractures. This was despite awareness that such atten-
dance involved listening to extraneous information and rely-
ing on clinicians including discussion of all relevant patients.
Perioperative or post-operative ward rounds were successfully
used to identify patients although participants were concerned
1. Case ﬁnding  
• Ease of idenﬁcaon
• Advantages and disadvantages of diﬀerent method s of case ﬁnding – computerised databases, 
aendance at trauma meengs, ward rounds
• Use of mulple methods of case ﬁnding
2. Osteoporosis assessment 
• Preference for inpaent seng 
• Orthogeriatricians Vs Fracture prevenon nurses to conduct assessment 
• Advantages and disadvantages of using pro formas 
• Timing of assessment 
DXA scanning 
• Adherence to NICE guidelines by DXA scanning those aged <75 and treang those aged ≥75 without 
• Preference for DXA scanning in outpaent seng 
• Preference for direct referral rather than via GPs 
• Lack of capacity to refer to scans 
3. Treatment iniaon 
Aged ≥75 
• Iniaon in inpaent seng where possible 
• Failure to prescribe treatments in inpaents 
• Failure to include treatments on discharge summaries / GPs to read summaries 
Aged <75 
• Therapies not being iniated consistently in primary care 
• Strategies to improve communicaon between secondary care and GPs 
• Wrien guidelines to help GPs make treatment decisions 
4. Monitoring 
• Preference for zoledronic acid among bisphosphonates with hope to improve adherence 
• Subopmal and inconsistent monitoring in primary care 
Monitoring by secondary care
• Advantages and disadvantages of diﬀerent methods of monitoring – quesonnaires, telephone calls 
and outpaent appointments 
• Limited capacity for follow-up 
• Timing of follow-up and priorisaon of paents 
Coordinaon of care
Co-ordinaon of care in secondary care 
• Coordinator-based models of care 
• Addional strategies for coordinang care including mul-disciplinary paperwork such as protocols 
and pro formas, joint ward rounds and mul-disciplinary team meengs 
Coordinaon of care between primary and secondary care 
• Lack of communicaon and cooperaon between primary and secondary care
• Strategies for addressing this – training sessions, developing local guidelines with GPs and receiving 
feedback on services from primary care
Fig. 1 Summary of healthcare professionals’ and service managers
experiences and views on the most effective ways of preventing
secondary fractures after hip fracture is identified in this study
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that patients seen perioperatively could be missed if they were
particularly ill.
Relying solely on trauma meetings or ward rounds was
problematic when staff were absent as it meant that there
was no one to identify cases. To mitigate this, participants
emphasised the importance of back-up such as computerised
databases to identify patients retrospectively. Multiple
methods were also used to provide a ‘backstop’ if patients
were overlooked, ‘someone who picks up, sweeps up behind’.
Osteoporosis assessment (Box 1)
There was consensus that osteoporosis assessments were best
done in an inpatient setting where possible to enable clinicians
to initiate bone protection therapies more quickly. Participants
believed that there was a risk of ‘losing’ patients after dis-
charge as at that time, they may not receive appointment let-
ters, may be too frail or forget to attend appointments.
Participants discussed the advantages and disadvantages of
the assessment being carried out by orthogeriatricians and
fracture prevention nurses. Orthogeriatricians were thought
to have the skillset to assess more complex patients. However,
some thought that this was an expensive model of care and a
large workload for clinicians who were also responsible for
carrying out falls assessments and optimising patients for the-
atre. Participants said patients saw fracture prevention nurses
as approachable and thought they had more time to spend with
patients than other professionals. These were thought to mean
that patients would provide better information to fracture pre-
vention nurses. This view was shared by participants from all
professional groups, and two fracture prevention nurses felt
that it could be useful for them to undertake a nurse prescrib-
ing course. Other participants had found a nurse-led model
with medical back-up from orthogeriatricians or metabolic
bone physicians was effective. Rheumatologists were also
seen to have a role in providing more specialized advice when
required on treatments such as in the first few months when
denosumab was available, atypical osteoporosis and less com-
mon secondary causes of osteoporosis.
Participants discussed the advantages and disadvantages of
using a pro forma when assessing patients. In straightforward
cases, they felt it enabled them to ensure that the assessment
was performed thoroughly and consistently. Others thought it
meant patient-specific factors could be overlooked and that
questions should be tailored to individual patients.
There was no consensus on the best time to conduct assess-
ment. Two participants felt that 48 h post operatively was long
enough to give patients time to recover from immediate effects
of the operation, and others felt that 4 or 5 days post opera-
tively was more appropriate. Most advocated flexibility de-
pending on the needs of individual patients. However, the
timing of the assessment was often constrained by the capacity
of the service. To assess cognitively impaired patients,
participants obtained assessment information from close rela-
tives or initiated treatment without a full assessment.
DXA scanning
The majority of participants were of the opinion that services
should adhere to NICE guidelines by providing DXA scans to
those aged under 75 and treating those aged ≥75 without the
absolute need for DXA [20]. Participants’ reasons for this
included the high levels of osteoporosis in those aged ≥75
and finite resources in the NHS. However, participants were
also flexible in this, for instance when patients ≥75 needed to
be presented with ‘proof’ before they would agree to start
taking treatments. One interviewee was concerned that the
NICE guideline meant some patients who would benefit from
a DXA scan were being overlooked.
The location of the DXA scan, whether in an inpa-
tient, outpatient or community hospital, was seen to im-
pact on whether patients received it. The majority of
participants felt that it was most appropriate to admin-
ister it in an outpatient setting. Nevertheless, one partic-
ipant favoured an inpatient setting since it meant he
could ensure patients received a scan and enabled him
to initiate treatment more quickly. However, he ac-
knowledged that scan provision was dependent on
whether patients were well enough.
Conducting a scan in the post-discharge outpatient
setting gave patients time to recover from their opera-
tion. But this idea was tempered by concern about fail-
ure of patients to attend appointments. This was seen as
being particularly problematic when patients lived a
long way from the scanner. Strategies for mitigating this
were ensuring that the scanner was accessible by having
good public transport links and providing transport to
those who were not able to reach the hospital. To en-
courage patients to attend appointments, one participant
thought it useful to emphasise the importance of a scan
to patients whilst they were still receiving inpatient care.
Another participant initiated treatment on the same day
as administering the scan so that patients only had to
attend one appointment and sent reminders prior to
appointments.
The process of referral to scans was seen as impor-
tant. Whilst some orthogeriatricians and fracture preven-
tion nurses described how they were able to refer pa-
tients directly, others had to request an appointment via
primary care. Interviewees felt the latter approach was
problematic as it meant patients had to wait longer,
delayed the start of treatment and made it more likely
that patients would ‘get lost’ in the system. Methods of
referral were constrained by contracting arrangements
with primary care which some found frustrating.
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A number of participants also highlighted the lack of ca-
pacity to refer patients to be DXA scanned and wanted more
frequent access or additional scanners in place.
Box 1 Case finding and osteoporosis assessment
Case finding
It depends which doctors have been on the night before as to how much
has been put onto [the computer system]… some of it turns out to be
rubbish [Participant ID: 010]
Osteoporosis assessment
I’d love to see a nurse specialist in there because I think some of those
older people are far less intimidated… to see a fracture nurse in that
setting actually exploring what those answers mean, getting the detail
would be brilliant. [Participant ID: 016]
You know breaking your hip is huge, there’s lots of psychological
things… Being flexible about [the timing] is probably a bit more
patient-centred. [Participant ID: 029]
DXA scanning
It really depends how able they are to get on and off the bed and stick their
legs in the air and that sort of thing. [Participant ID: 008]
I think having it done as an Outpatient is more appropriate because most
of them are generally quite sick or unwell or they’re still in pain so it
would be difficult to get them to the DEXA. [Participant ID: 019]
Our biggest barrier is obviously the fact that we have to drag our patients
from [another town] down to [the city]. [Participant ID: 004]
We should just be able to refer directly… It just adds in an additional
communication where we know there’s problems, where referral forms
get missed, go missing, patients fail to attend their appointment and no
one follows that up. [Participant ID: 030]
The powers that be… don’t like us DEXA-ing people internally, because
they like the money flow, so they prefer them to go out and then come
back. [Participant ID: 009]
Treatment initiation (Box 2)
Aged 75 and over
Participants were asked to discuss their experiences of initiat-
ing a range of bone protection therapies including
bisphosphonates, raloxifene, strontium ranelate, denosumab
and teriparatide [8, 20, 21]. They felt that patients who were
≥75 and who did not need a DXA scan should have their
treatment initiated in an inpatient setting where possible. This
meant they could begin treatments more quickly and enabled
clinicians to assess whether they could tolerate it. However,
some clinicians were concerned that patients were sometimes
too ‘shocked’ post operatively to understand how and why
they were taking the therapies which could impact on adher-
ence. They therefore stressed the need to follow this informa-
tion up post-discharge. Others were worried that treatments
were being initiated before clinicians could get a ‘feel’ for
their prognosis.
Some participants were worried that patients were not be-
ing prescribed treatments whilst they were inpatients. One
clinician had found it useful to put ‘checks’ in place so that
their colleagues were able to spot if they had not been pre-
scribed. Furthermore, treatments were not always included on
discharge summaries. To mitigate this, participants thought it
could be useful to build automated reminders into electronic
patient records or use more senior staff to write summaries.
There was also a concern that discharge summaries were not
always read by GPs. To address this, one participant had re-
placed formal letters with a shorter, more concise report.
Aged under 75
For those aged under 75 who received a DXA scan or who
needed treatments that could not be initiated immediately [20],
therapies were either initiated in primary care or in an outpa-
tient setting. However, there was a concern that this was not
being done consistently in primary care and that GPs lacked
‘alertness’ about the importance of the therapies.
To help GPs make appropriate treatment decisions,
healthcare professionals in secondary care often sent treatment
recommendations and DXA reports. Improvements in written
communication were suggested to encourage GPs to read
them. One participant thought it would be useful to issue pro
formas to GPs to help them make decisions. In one service,
healthcare professionals had issued written guidelines but had
struggled to ensure they were accessible enough for GPs to
use them regularly.
Monitoring (Box 2)
Of the areas explored, participants were most concerned
about the low levels of adherence to bone protection
therapies and felt that monitoring had the potential to
imp rove adhe r en c e t o o r a l t h e r a p i e s . S i n c e
bisphosphonates are generally the first line of treatment
for osteoporosis in the UK [8], a number of participants
thought that zoledronic acid should be made more wide-
ly available. They felt this could help improve adher-
ence since it is given at a clinic rather than at home and
given once a year rather than being taken regularly.
However, they also described how the provision of this
therapy was often constrained by local guidelines.
By primary care
Patients prescribed oral bisphosphonates were generally mon-
itored in primary care. However, there was a worry that this
management was often ‘sub-optimal’ and some participants
were concerned that GPs did not always have enough knowl-
edge to monitor patients effectively.
Participants thought that the introduction of the Quality
Outcomes Framework in primary care [22] was of limited
use since it did not provide a large enough financial incentive
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to primary care to deliver effective services. To address these
problems, participants thought it would be useful to introduce
osteoporosis champions and fracture prevention nurses into
primary care to provide GPs with support and guidance in
setting up and delivering services. They also thought ‘open
communication’ was important and used letters, emails and
phone calls to communicate with GPs. However, one partici-
pant felt that these were only utilised by those who were in-
terested in the disease.
By secondary care
On account of these problems, participants thought that more
monitoring could be conducted by secondary care. However,
there was no consensus on how this could be systematically
achieved. Participants discussed the relative advantages and
disadvantages of using questionnaires, telephone calls and
outpatient’s appointments to perform monitoring.
Questionnaires were used as a ‘prompt’ to call pa-
tients or GPs if a problem was identified and were not
time consuming to administer. However, participants felt
relevant information may be missed out and had expe-
rienced a ‘poor’ return rate. Contacting patients by
phone allowed participants to ask ‘prompting questions’
to obtain information. Because of this, participants felt
it was best done by someone with clinical knowledge.
However, there was no capacity for this type of follow-
up by some services. Others wanted to follow up pa-
tients in outpatient clinics as it was ‘easier to assess
patients face-to-face’. However, most felt it was unnec-
essary and lacked the resources to do so.
Some participants had found it difficult to contact nursing
homes as staff were busy and therefore difficult to get hold of.
In these cases, they thought it might be easier to use question-
naires that they could complete in their own time. Another
undertook a ‘ward round’ so he could obtain information from
relatives or members of staff.
Participants felt the purpose of monitoring was to reiterate
the importance of adherence, ensure that this was being done
properly and to clarify instructions if necessary, and identify
any problems such as swallow issues that meant other thera-
pies such as zoledronic acid were more appropriate.
Since there was limited capacity for follow-up in
many of the services, the majority of participants
prioritised follow-up between 6 and 12 weeks as it en-
abled them to ‘catch’ those who were not adhering and
‘give them a second go’. It was felt this was a suitable
length of time to revisit the information provided on
discharge before it had been forgotten. Some partici-
pants also suggested targeting individual patients. One
participant felt it was important to be flexible with this
depending on the needs of individuals.
Box 2 Treatment initiation and monitoring (to enhance
adherence)
Treatment initiation
Aged 75 and over
I don’t think there’s an option for it to be initiated in Primary Care for us at
the moment because even when we send people home on it the GPs
don’t always continue it [Participant ID: 017]
It’s not missed because if I missed it the nurses would pick up… the
Fracture Liaison Nurses would pick it up or the Pharmacist would, you
know there are various checks that they wouldn’t go out without their
bone protection. [Participant ID: 005]
GPs get probably 400 or 500 letters a day, do they read everything?
Hopefully they do. [Participant ID: 035]
Aged under 75
[We] don’t know howmany have treatment initiated [byGPs] [Participant
ID: 017]
It’s almost like [GPs] need a package of almost instructions with a tick
box… so that yeah it’s straight forward for them. [Participant ID: 037]
I think that there are sort of conflicts in having guidelines that are actually
useful in making an individual treatment decision whilst being
sufficiently simplistic enough for someone to be able to commit to
memory and remember. [Participant ID: 024]
GPs are fantastic, but how can they be experts and know everything…
And that’s why I think we have a duty to them and to our patients to
inform appropriately. [Participant ID: 042]
Monitoring
We know that compliance is the issue, and we know that less than 50 %
are taking them at the year mark. [Participant ID: 010]
By primary care
This has to be owned by Primary Care, I mean this is a long term
condition, osteoporosis and fracture prevention, and GPs are
responsible for managing long term conditions [Participant ID: 026]
I think in the hospital we have to remember that these are the GP’s patients
not our patients…we have to put responsibility onto the GP and onto the
patients tomake sure that they do take their tablets. It’s a bit buck passing
really but that’s how it needs to be [Participant ID: 002]
Well in theory the GPs should be monitoring these patients… But it
doesn’t happen. It might happen on the odd GP, but that isn’t
happening [Participant ID: 011].
The GPs that liaise with you are probably the GPs that you’re not worried
about because they are trying to improve their knowledge; it’s the ones
that you never hear about that never call you that think they can
manage this condition that they can’t [Participant ID: 020]
By secondary care
The patients didn’t realise [taking the medication] was that important, I
don’t think. Whereas if they’re getting a phone call at three months to
check they’re going to think, BWell it must be important because
they’re phoning me to see if I’m taking the tablet. Oh I’d better carry on
taking it. [Participant ID: 010]
It was a waste for them coming in, ten minute appointment, and it was a
waste of a clinic slot that could be done for someone that is struggling
or not responding or needing treatment. [Participant ID: 042]
Usually [undertaking a ward round in a nursing home] is simpler than the
patient coming here and if the patients come here they usually come
with an escort who doesn’t have additional information, whereas if we
go there the patient has the nurses that have been looking after the
patient and we get a lot more information from them that way.
[Participant ID: 038]
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I would like far more time to be able to follow these patients up more
thoroughly [Participant ID: 002]
I just don’t have the resource to [follow-up] [Participant ID: 023]
Six months down the line, the horse has already bolted and they won’t
remember what you said beforehand, so I think three months is at least
the initial thing [Participant ID: 024]
[6 – 12 weeks is] a nice length of time to revisit all the information you
gave them at the diagnosis, and make sure that they’re understanding
everything, and that you can go through the lifestyle again… I think
any sooner would be too quick, and maybe a bit longer is too long.
[Participant ID: 042]
So [monitoring] doesn’t become so unwieldy… identify your patients
that you really need to follow up and identify the patients that you may
[Participant ID: 028]
It’s more that you need flexibility within the service to be able to account
for the differences in individuals. [Participant ID: 024]
Coordination of care (Box 3)
Participants discussed their experiences of coordinating the
multi-disciplinary teams involved in fracture prevention.
Coordinator-based models of care
All interviewees advocated using a dedicated coordinator to
coordinate the multi-disciplinary teams, whether this be a frac-
ture prevention nurse or consultant-led service. Participants
felt it was useful to have a coordinator that ‘know[s] who’s
who and who to contact’ and who could provide a link to other
wards if it was necessary. They also felt coordinators provided
‘continuity of care’ for patients which helped them to build
more trusting relationships. Some thought it was best to have a
number of clinicians responsible for this so that if a colleague
was absent, there was someone who could fulfil this role.
Additional strategies for coordinating care
Other strategies for coordinating care were discussed. Partic-
ipants felt that multi-disciplinary paperwork such as protocols
and pro formas were useful as they meant colleagues had
access to all the information that could help them make a
treatment decision and that tests were less likely to be dupli-
cated. Some thought that electronic patient records were the
most efficient way of transferring this information. Joint ward
rounds were also used and ensured that no information was
forgottenwhen it was transferred to colleagues. Regular multi-
disciplinary meetings helped to ensure that the team commu-
nicated regularly and enabled colleagues to develop a ‘mutual
professional respect’. Informal communication was also seen
to be important.
Coordination of care between primary and secondary care
Participants felt that there was a lack of communication and
cooperation between primary and secondary care. Training
sessions had been used to try and address this. However, al-
though some had found them useful, others felt that ‘you only
get the ones that are interested’ and had cancelled sessions due
to a lack of interest. Other participants thought it might be
useful to develop local guidelines with GPs and contact them
for feedback on their services.
Box 3 Coordination of care
Are they having that continuity of care, are they having a regular
orthogeriatric input? No, and I think that’s something that we can
improve upon [Participant ID: 006]
Coordinator-based models of care
It needs a strong lead, it needs a me or equivalent of me really… In terms
of the Orthopaedic Team, you know you’re working with Orthopaedic
Nurses so it’s a different culture set… So you need to sort of pull in the
ethos [Participant ID: 026]
There is a communication pathway which we never had before
[Participant ID: 008]
You often establish relationships and people can become more trusting
and they can tell you if they’re actually taking their medications or not
[Participant ID: 022]
Well the only problem we have is the service is so good when she’s here;
it’s a problem when she’s not. [Participant ID: 001]
Additional strategies for coordinating care
It’s much easier to communicate with people that are on the end of the
phone and because we have meetings every month [Participant ID:
009]
It’s just about encouraging people to know that they all have a role, we all
have a responsibility to deliver the quality care and all of us are
important in making that so. You know each of you can’t do it without
the other and it’s actually about ownership and responsibility
[Participant ID: 026]
Coordination of care between primary and secondary care
There seem to be very – two separate camps: there’s what actually
happens in trauma and then there’s what happens in primary care, and
the communication is difficult. [Participant ID: 009]
I don’t think it’s very good at all… its very much them and us isn’t it
situation. [Participant ID: 002]
It’s about making sure GPs are happy with that and they are happy
because they’ve been involved in the decision making. [Participant ID:
002]
I mean it is a big hole really, we ought to find out what they think of the
discharge summaries and things… I suppose I need to go back to the
GPs and say Bwell what do you think of this service now? [Participant
ID: 004]
Discussion
This study supports existing guidance and research on the best
models of care for the prevention of secondary fractures. This
includes the value of using a dedicated clinician to perform
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case finding [1], provision of DXA scans to those aged under
75 years and initiating treatment for those aged ≥75 without a
DXA [20]. Using fracture prevention nurses as fracture pre-
vention coordinators with medical back-up, which was advo-
cated by a number of participants, is also the model proposed
by the Department of Health [23]. Concern about the low
levels of adherence to bone protection therapies reflects find-
ings from previous studies [24]. Although no studies have
examined adherence to zoledronic acid compared to oral ther-
apies, the high levels of adherence to zoledronic acid has been
demonstrated [25] along with patient preference for this ther-
apy [26]. More recent data has confirmed high rates of adher-
ence to denosumab [27]. The use of monitoring to improve
adherence is also well established [28]. To coordinate the
multi-disciplinary teams involved in fracture prevention, there
is also an international consensus about the need for
coordinator-based models of care [11, 12, 29–31]. This study
expands on this by exploring participants’ views on the best
ways of enacting these guidelines and the challenges they
encountered in doing so. Surprisingly, there was no consensus
on the best time to conduct assessment. One of the biggest
issues identified was the failure of primary and secondary care
to communicate effectively, especially with regard to treat-
ment initiation in primary care. Issuing guidance on these
would provide clarity and help clinicians to address these
challenges. Participants also challenged guidelines which sug-
gest GPs are best placed to monitor adherence to treatments
[1] and thought more could be done by secondary care. Since
effective fracture prevention is a global concern [11], it is
possible that these findings may be usefully applied to other
care settings. It is worth noting that although we recognise the
nature of the biological assessments being carried out prior to
treatment initiation is crucial, we felt this subject was best
suited to clinical studies.
A qualitative study design using interviews enabled us to
identify and explore the views and experiences of profes-
sionals working in the area of fracture prevention. Employing
open-ended questions but focusing on known areas for frac-
ture prevention was designed to enable professionals to speak
candidly about their experiences. The sample comprised 43
participants, who were purposively sampled to ensure that all
professional groups were represented. The study did not seek
to achieve saturation as in some qualitative research but
sought to achieve an appropriate sample providing adequate
representation of involved professionals [32]. Unless appro-
priate, we do not distinguish between the views of different
groups of professionals working within the field as we found
that there was little difference in their perspectives except that
clinically trained staff were able to reflect on clinical practice,
whereas it was not the place of managers to do so. The study
only took place in one region, and although it included all
NHS trusts in that region, further work may be needed to
explore fracture prevention services in other areas.
Furthermore, it is possible that participants’ experiences of
working with primary care may not reflect the perceptions of
GPs, which could be the subject for a further study.
The study has successfully explored the best models
of care for the prevention of fractures after hip fracture.
Identifying these will help inform clinicians and service
managers about how to develop fracture prevention ser-
vices in the future. Further work could explore the de-
livery of fracture prevention services in primary care.
This would offer a ‘system-wide’ perspective which
would over arch the division between primary and sec-
ondary care. Further research could also explore the
experiences of patients with hip fracture and their sig-
nificant others of accessing these services to add a ‘pa-
tient-centred’ context to the organisation of services. In
addition, whilst the study focused on fracture prevention
rather than falls prevention services, we acknowledge
that these are interrelated [1] and further work could
be conducted on this area. There is also a clear need
to understand the most effective ways of monitoring
patients to improve adherence to ensure that they expe-
rience the full benefits of bone protection therapies. In
addition, it may be of value to explore experiences of
delivering fracture prevention in other care settings.
This would provide information on how to deliver ser-
vices effectively elsewhere.
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